139 related articles for article (PubMed ID: 22586143)
1. ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1.
Pan Y; Han C; Wang C; Hu G; Luo C; Gan X; Zhang F; Lu Y; Ding X
J Mol Endocrinol; 2012 Aug; 49(1):21-33. PubMed ID: 22586143
[TBL] [Abstract][Full Text] [Related]
2. SRC fine-tunes ADAM10 shedding activity to promote pituitary adenoma cell progression.
Huang J; Pan Y; Hu G; Sun W; Jiang L; Wang P; Ding X
FEBS J; 2020 Jan; 287(1):190-204. PubMed ID: 31365784
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10.
Murai T; Miyauchi T; Yanagida T; Sako Y
Biochem J; 2006 Apr; 395(1):65-71. PubMed ID: 16390331
[TBL] [Abstract][Full Text] [Related]
4. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
[TBL] [Abstract][Full Text] [Related]
5. A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44.
Stoeck A; Keller S; Riedle S; Sanderson MP; Runz S; Le Naour F; Gutwein P; Ludwig A; Rubinstein E; Altevogt P
Biochem J; 2006 Feb; 393(Pt 3):609-18. PubMed ID: 16229685
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
7. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
8. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
9. ADAM10: a new player in breast cancer progression?
Mullooly M; McGowan PM; Kennedy SA; Madden SF; Crown J; O' Donovan N; Duffy MJ
Br J Cancer; 2015 Sep; 113(6):945-51. PubMed ID: 26284334
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tunicamycin-induced CD44v6 ectodomain shedding and apoptosis is correlated with temporal expression patterns of active ADAM10, MMP-9 and MMP-13 proteins in Caki-2 renal carcinoma cells.
Kim YH; Jung JC
Oncol Rep; 2012 Nov; 28(5):1869-74. PubMed ID: 22923171
[TBL] [Abstract][Full Text] [Related]
11. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
12. ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.
Guo J; He L; Yuan P; Wang P; Lu Y; Tong F; Wang Y; Yin Y; Tian J; Sun J
Oncol Rep; 2012 Nov; 28(5):1709-18. PubMed ID: 22940701
[TBL] [Abstract][Full Text] [Related]
13. Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling.
Woods N; Trevino J; Coppola D; Chellappan S; Yang S; Padmanabhan J
Oncotarget; 2015 Nov; 6(34):35931-48. PubMed ID: 26440150
[TBL] [Abstract][Full Text] [Related]
14. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
15. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
[TBL] [Abstract][Full Text] [Related]
16. Nuclear translocation and signalling of L1-CAM in human carcinoma cells requires ADAM10 and presenilin/gamma-secretase activity.
Riedle S; Kiefel H; Gast D; Bondong S; Wolterink S; Gutwein P; Altevogt P
Biochem J; 2009 May; 420(3):391-402. PubMed ID: 19260824
[TBL] [Abstract][Full Text] [Related]
17. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
18. N-terminal cleavage and release of the ectodomain of Flt1 is mediated via ADAM10 and ADAM 17 and regulated by VEGFR2 and the Flt1 intracellular domain.
Raikwar NS; Liu KZ; Thomas CP
PLoS One; 2014; 9(11):e112794. PubMed ID: 25387128
[TBL] [Abstract][Full Text] [Related]
19. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
[TBL] [Abstract][Full Text] [Related]
20. Engagement of CD44 promotes Rac activation and CD44 cleavage during tumor cell migration.
Murai T; Miyazaki Y; Nishinakamura H; Sugahara KN; Miyauchi T; Sako Y; Yanagida T; Miyasaka M
J Biol Chem; 2004 Feb; 279(6):4541-50. PubMed ID: 14623895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
